Commercially available antibodies are typically poorly characterized and supplier statements on intended use are not necessarily reliable. Surface plasmon...

Watch our discussion on the expanding field of targeted protein degradation and the technologies used to characterize these unique molecules. In this emerg...

The fiber pads you use in your lateral flow assays can affect performance and results. Choosing the right fiber pad can ensure test-to-test reproducibility...

According to data from our 2023 Global Biopharma Resilience Index, 55% of pharma leaders are happy with the speed of drug approvals — meaning 45% feel ther...

Robust and reproducible analytical method for product development and quality control

Learn all about Fast Trak™ services from Cytiva from our very own Fast Trak™ Global Technical Leader, Sabrina Carmichael. In this video, you’ll get an over...

As the trend towards subcutaneous drug administration grows and drug formulations become more concentrated, careful consideration is required when selectin...

Novel therapeutics are bursting onto the scene at a rapid rate as innovators race to harness the power of mRNA, cell therapies, and other gene-based treatm...

Introducing new Cytiva™ Protein Select™ resin - For recombinant protein purification in research and process development By Emma Lind, Product Manager at ...

The separation of adeno-associated virus (AAV) with high yield and purity is an increasingly important challenge. Mechanistic modeling is the tool of choic...